Publications - IR Sant Pau

Search

01/01/2022 Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial

Pasquali, S, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Lopez-Pousa, A, Grignani, G, Brunello, A, Blay, JY, Tendero, O, Diaz-Beveridge, R, Ferraresi, V, Lugowska, I, Infante, G, Braglia, L, Merlo, DF, Fontana, V, Marchesi, E, Donati, DM, Palassini, E, Bianchi, G, Marrari, A, Morosi, C, Stacchiotti, S, Bague, S, Coindre, JM, Dei Tos, AP, Picci, P, Bruzzi, P, Miceli, R, Casali, PG, Gronchi, A. Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial. CANCER. 2022; 128(1)DOI:10.1002/cncr.33895. PMID:34643947. IF:6.200(Q1/3D).

01/12/2021 A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin

Moura, DS, Pena-Chilet, M, Varela, JAC, Alvarez-Alegret, R, Agra-Pujol, C, Izquierdo, F, Ramos, R, Ortega-Medina, L, Martin-Davila, F, Castilla-Ramirez, C, Hernandez-Leon, CN, Romagosa, C, Salgado, MAV, Lavernia, J, Bague, S, Mayodormo-Aranda, E, Vicioso, L, Barcelo, JEH, Rubio-Casadevall, J, de Juan, A, Fiano-Valverde, MC, Hindi, N, Lopez-Alvarez, M, Lacerenza, S, Dopazo, J, Gutierrez, A, Alvarez, R, Valverde, C, Martinez-Trufero, J, Martin-Broto, J. A DNA damage repair gene-associated signature predicts responses of patients with advanced soft-tissue sarcoma to treatment with trabectedin. Molecular Oncology. 2021; 15(12)DOI:10.1002/1878-0261.12996. PMID:33983674. IF:7.449(Q1/3D).

01/12/2021 Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial

Martin-Broto, J, Lopez-Alvarez, M, Moura, DS, Ramos, R, Collini, P, Romagosa, C, Bague, S, Renne, SL, Barisella, M, Velasco, V, Coindre, JM, Lopez-Lopez, D, Dopazo, J, Gambarotti, M, Braglia, L, Merlo, DF, Palmerini, E, Stacchiotti, S, Quagliuolo, VL, Lopez-Pousa, A, Grignani, G, Blay, JY, Brunello, A, Gutierrez, A, Valverde, C, Hindi, N, Dei Tos, AP, Picci, P, Casali, PG, Gronchi, A. Predictive Value of MRP-1 in Localized High-Risk Soft Tissue Sarcomas: A Translational Research Associated to ISG-STS 1001 Randomized Phase III Trial. MOLECULAR CANCER THERAPEUTICS. 2021; 20(12)DOI:10.1158/1535-7163.MCT-21-0315. PMID:34552008. IF:6.011(Q2/3D).

01/08/2021 Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines

Alamo, P, Cedano, J, Conchillo-Sole, O, Cano-Garrido, O, Alba-Castellon, L, Serna, N, Avino, A, Carrasco-Diaz, LM, Sanchez-Chardi, A, Martinez-Torro, C, Gallardo, A, Cano, M, Eritja, R, Villaverde, A, Mangues, R, Vazquez, E, Unzueta, U. Rational engineering of a human GFP-like protein scaffold for humanized targeted nanomedicines. Acta Biomaterialia. 2021; 130DOI:10.1016/j.actbio.2021.06.001. PMID:34116228. IF:10.633(Q1/2D).

01/07/2021 Atypical Endometrial Hyperplasia, Low-grade "Much ADO About Nothing"

D'Angelo, E, Espinosa, I, Cipriani, V, Szafranska, J, Barbareschi, M, Prat, J. Atypical Endometrial Hyperplasia, Low-grade "Much ADO About Nothing". AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2021; 45(7)DOI:10.1097/PAS.0000000000001705. PMID:34105519. IF:6.298(Q1/1D).

01/07/2021 A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report

Moura, DS, Diaz-Martin, J, Bague, S, Orellana-Fernandez, R, Sebio, A, Mondaza-Hernandez, JL, Salguero-Aranda, C, Rojo, F, Hindi, N, Fletcher, CDM, Martin-Broto, J. A Novel NFIX-STAT6 Gene Fusion in Solitary Fibrous Tumor: A Case Report. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(14)DOI:10.3390/ijms22147514. PMID:34299133. IF:6.208(Q1/3D).

01/07/2021 Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study

Vieites, B, Lopez-Garcia, MA, Martin-Salvago, MD, Ramirez-Tortosa, CL, Rezola, R, Sancho, M, Lopez-Vilaro, L, Villardell, F, Burgues, O, Fernandez-Rodriguez, B, Alfaro, L, Peg, V. Predictive and prognostic value of total tumor load in sentinel lymph nodes in breast cancer patients after neoadjuvant treatment using one-step nucleic acid amplification: the NEOVATTL study. Clinical & Translational Oncology. 2021; 23(7)DOI:10.1007/s12094-020-02530-4. PMID:33517542. IF:3.340(Q3/7D).

01/03/2025 CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model

Szafranska, J, Batto, V, Alcaraz, J, Guinart-Cuadra, A, Brujats, A, Fajardo, J, Acin, V, Garcia, H, Casani, L, Villanueva, C, Ferré, M, del Olmo, TV, Tapias, EA. CT-FIRE a Novel Technique in Quantitative Image Analysis of Collagen Fibers in Chronic Liver Disease Regression Animal Model. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103704. PMID:. IF:4.200(Q1/1D).

01/03/2025 Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens

Kelley, J, Hissong, E, Szafranska, J, Qin, LH, Lamps, L, Jessurun, J. Clinical Significance and Morphologic Characteristics of Non-Amyloid Heavy and Light Chain Deposition Disease in Gastrointestinal Mucosal Biopsy Specimens. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.102849. PMID:. IF:4.200(Q1/1D).

01/03/2025 Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas

D'Angelo, E, Kingsley, L, Espinosa, I, Cipriani, V, Marotta, A, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. Digital Spatial Profiling (DSP) Identifies Different Molecular Signatures Between Uterine Atypical Polyps and Adenosarcomas. LABORATORY INVESTIGATION. 2025; 105(3)DOI:10.1016/j.labinv.2024.103197. PMID:. IF:4.200(Q1/1D).

01/01/2025 A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation

Carrasco-Díaz, LM, Gallardo, A, Voltà-Durán, E, Virgili, AC, Paez, D, Villaverde, A, Vazquez, E, Alamo, P, Unzueta, U, Casanova, I, Mangues, R, Alba-Castellon, L. A Targeted Nanotoxin Inhibits Colorectal Cancer Growth Through Local Tumor Pyroptosis and Eosinophil Infiltration and Degranulation. International Journal of Nanomedicine. 2025; 20DOI:10.2147/IJN.S499192. PMID:40034221. IF:6.500(Q1/1D).

01/12/2024 HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study

Moura, DS, Mondaza-Hernandez, JL, Sanchez-Bustos, P, Peña-Chilet, M, Cordero-Varela, JA, Lopez-Alvarez, M, Carrillo-Garcia, J, Martin-Ruiz, M, Romero-Gonzalez, P, Renshaw-Calderon, M, Ramos, R, Marcilla, D, Alvarez-Alegret, R, Agra-Pujol, C, Izquierdo, F, Ortega-Medina, L, Martin-Davila, F, Hernandez-Leon, CN, Romagosa, C, Salgado, MAV, Lavernia, J, Bagué, S, Mayodormo-Aranda, E, Alvarez, R, Valverde, C, Martinez-Trufero, J, Castilla-Ramirez, C, Gutierrez, A, Dopazo, J, Hindi, N, Garcia-Foncillas, J, Martin-Broto, J. HMGA1 regulates trabectedin sensitivity in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) study. CELLULAR AND MOLECULAR LIFE SCIENCES. 2024; 81(1)DOI:10.1007/s00018-024-05250-y. PMID:38758230. IF:6.200(Q1/2D).

01/10/2024 From the Rare to the Extraordinary Pancreatic Serous Cystadenocarcinoma With Hepatic and Bone Dissemination: A Letter to the Editor

Cardozo, A, Lleida, R, Szafranska, J, Piñol, D, Serdà, P, Martin-Cullell, B, Manrique, A, López-Bravo, D, Mateo, FJ. From the Rare to the Extraordinary Pancreatic Serous Cystadenocarcinoma With Hepatic and Bone Dissemination: A Letter to the Editor. PANCREAS. 2024; 53(9)DOI:10.1097/MPA.0000000000002362. PMID:39250559. IF:1.700(Q3/8D).

01/10/2024 RET overexpression in absence of fusions or mutations associates with sensitivity to RET TKIs in lung cancer

Sullivan, I, Aguado, C, Baroni, M, Teixeira, S, Bertran, J, Giménez, A, Aldeguer, E, Román, R, Reguart, N, López, L, Cavagna, R, Marín, E, García, B, Rodriguez, S, Rosell, R, Ferro, L, Chae, Y, Reis, R, Molina, MA. RET overexpression in absence of fusions or mutations associates with sensitivity to RET TKIs in lung cancer. EUROPEAN JOURNAL OF CANCER. 2024; 211DOI:10.1016/j.ejca.2024.114800. PMID:. IF:7.100(Q1/2D).

01/09/2024 ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer

Barba, A, López-Vilaró, L, Ferre, M, Majem, M, Martinez-Recio, S, Bell, O, Arranz, MJ, Salazar, J, Sullivan, I. ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer. Pharmaceutics. 2024; 16(9)DOI:10.3390/pharmaceutics16091121. PMID:39339159. IF:5.500(Q1/1D).

01/09/2024 Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series

Prat, A, Piñol, D, Espadaler, I, Campazas, I, Espinosa, I, Fusté, V, Szafranska, J, Fumagalli, C. Pancreatic adenocarcinoma associated with intraductal papillary mucinous neoplasm: a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).

01/09/2024 NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series

Prat, A, Di Muro, MA, Acosta, SF, Vazquez, T, Rosell, SB, Orellana, R, Fumagalli, C. NKX2.2 expression in Ewing sarcoma: differences in sensitivity between pre-treatment biopsy and surgical specimen - a case series. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).

01/09/2024 Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor

Carrillo-García, J, Hindi, N, Conceicao, M, Sala, MA, Ugalde, A, López-Pousa, A, Bagué, S, Sevilla, I, Vicioso, L, Ramos, R, Martínez-Trufero, J, Mateo, MCG, Cruz, J, Hernández-León, CN, Redondo, A, Mendiola, M, García, JM, Hernández, JE, Alvarez, R, Agra, C, de Juan-Ferré, A, Valverde, C, Cano, JM, de Sande, LM, Pérez-Fidalgo, JA, Lavernia, J, Marcilla, D, Gutiérrez, A, Moura, DS, Martín-Broto, J. Prognostic impact of tumor location and gene expression profile in sporadic desmoid tumor. EUROPEAN JOURNAL OF CANCER. 2024; 209DOI:10.1016/j.ejca.2024.114270. PMID:39142211. IF:7.100(Q1/2D).

01/08/2024 Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy

Pasquali, S, Vallacchi, V, Lalli, L, Collini, P, Barisella, M, Romagosa, C, Bague, S, Coindre, JM, Dei Tos, AP, Palmerini, E, Quagliuolo, V, Martin-Broto, J, Lopez-Pousa, A, Grignani, G, Blay, JY, Beveridge, RD, Casiraghi, E, Brich, S, Renne, SL, Bergamaschi, L, Vergani, B, Sbaraglia, M, Casali, PG, Rivoltini, L, Stacchiotti, S, Gronchi, A. Spatial distribution of tumour immune in fi ltrate predicts outcomes of patients with high-risk soft tissue sarcomas after neoadjuvant chemotherapy. EBioMedicine. 2024; 106DOI:10.1016/j.ebiom.2024.105220. PMID:39018755. IF:10.800(Q1/1D).

01/07/2024 Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging

Espinosa, I, D'Angelo, E, Prat, J. Endometrial carcinoma: 10 years of TCGA (the cancer genome atlas): A critical reappraisal with comments on FIGO 2023 staging. GYNECOLOGIC ONCOLOGY. 2024; 186DOI:10.1016/j.ygyno.2024.04.008. PMID:38615479. IF:4.100(Q1/1D).

01/06/2024 CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas

Virgili, AC, Salazar, J, Gallardo, A, López-Pousa, A, Terés, R, Bagué, S, Orellana, R, Fumagalli, C, Mangues, R, Alba-Castellón, L, Unzueta, U, Casanova, I, Sebio, A. CXCR4 Expression as a Prognostic Biomarker in Soft Tissue Sarcomas. Diagnostics. 2024; 14(11)DOI:10.3390/diagnostics14111195. PMID:38893721. IF:3.300(Q1/2D).

01/06/2024 Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis

Cullell, BM, Manrique, ACV, Piedra, A, Fumagalli, C, Mateo, FJP, Serda, PC, Mirallas, O, Martínez, E, Trujillo, JC, Belda-Sanchis, J, Szafranska, J, Paez, D. Immune phenotypes and histological growth patterns in resected lung metastasis of colorectal cancer patients to assess prognosis. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/j.annonc.2024.05.133. PMID:. IF:65.400(Q1/1D).

01/04/2024 RET Fusion Testing in Patients With NSCLC: The RETING Study

Conde, E, Hernandez, S, Carrillo, JLR, Martinez, R, Alonso, M, Curto, D, Jimenez, B, Caminoa, A, Benito, A, Garrido, P, Clave, S, Arriola, E, Esteban-Rodriguez, I, De Castro, J, Sansano, I, Felip, E, Rojo, F, Dómine, M, Abdulkader, I, Garcia-Gonzalez, J, Teixido, C, Reguart, N, Compañ, D, Insa, A, Mancheño, N, Palanca, S, Juan-Vidal, O, Baixeras, N, Nadal, E, Cebollero, M, Calles, A, Martin, P, Salas, C, Provencio, M, Aranda, I, Massuti, B, Lopez-Vilaro, L, Majem, M, Paz-Ares, L, Lopez-Rios, F. RET Fusion Testing in Patients With NSCLC: The RETING Study. Jto Clinical And Research Reports. 2024; 5(4)DOI:10.1016/j.jtocrr.2024.100653. PMID:38525319. IF:(Q/D).

10/03/2024 Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG)

Gronchi, A, Palmerini, E, Quagliuolo, V, Broto, JM, Pousa, AL, Grignani, G, Brunello, A, Blay, JY, Tendero, O, Beveridge, RD, Ferraresi, V, Lugowska, I, Pizzamiglio, S, Verderio, P, Fontana, V, Donati, DM, Palassini, E, Sanfilippo, R, Bianchi, G, Bertuzzi, A, Morosi, C, Pasquali, S, Stacchiotti, S, Bagué, S, Coindre, JM, Miceli, R, Dei Tos, AP, Casali, PG. Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG). JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(8)DOI:10.1200/JCO.23.00908. PMID:38232337. IF:41.900(Q1/1D).

01/03/2024 Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy

Arqueros, C, Gallardo, A, Vidal, S, Osuna-Gómez, R, Tibau, A, Bell, OL, Cajal, T, Lerma, E, Lobato-Delgado, B, Salazar, J, Barnadas, A. Clinical Relevance of Tumour-Infiltrating Immune Cells in HER2-Negative Breast Cancer Treated with Neoadjuvant Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2024; 25(5)DOI:10.3390/ijms25052627. PMID:38473874. IF:4.900(Q1/3D).

01/03/2024 A Clinicopathologic and Immunohistochemical Analysis of 46 Uterine Mesenchymal Tumors Including Conventional Adenosarcomas, Atypical Uterine Polyps and Other Related Sarcomas

Angelo, ED, Espinosa, I, Wang, AH, Kingsley, L, Nasr, S, Zdravkovic, S, Howitt, B, Prat, J. A Clinicopathologic and Immunohistochemical Analysis of 46 Uterine Mesenchymal Tumors Including Conventional Adenosarcomas, Atypical Uterine Polyps and Other Related Sarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).

01/03/2024 Loss of Expression of ARID1a and PBRM1 Proteins Is Associated with Poor Prognosis in Mullerian Adenosarcomas

Espinosa, I, D'Angelo, E, Gallardo, A, Lee, CH, Koebel, M, Prat, J. Loss of Expression of ARID1a and PBRM1 Proteins Is Associated with Poor Prognosis in Mullerian Adenosarcomas. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).

01/03/2024 Tumor Microenvironment in Dedifferentiated and Undifferentiated Endometrial Carcinomas: The Emerging Role of Spatial Cancer-Immunophenotypes and HLA Class I Expression

De Leo, A, Ceccarelli, C, Grillini, M, de Biase, D, Tallini, G, Espinosa, I, Koebel, M, Lee, CH. Tumor Microenvironment in Dedifferentiated and Undifferentiated Endometrial Carcinomas: The Emerging Role of Spatial Cancer-Immunophenotypes and HLA Class I Expression. LABORATORY INVESTIGATION. 2024; 104(3)DOI:. PMID:. IF:4.200(Q1/1D).

10/08/2023 Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins

Álamo P., Parladé E., Favaro, MTP, Gallardo A., Mendoza R., Ferreira, LCS, Roher N., Mangues R., Villaverde A., Vázquez E.. Probing the Biosafety of Implantable Artificial Secretory Granules for the Sustained Release of Bioactive Proteins. ACS Applied Materials & Interfaces. 2023; 15(33)DOI:10.1021/acsami.3c08643. PMID:37614001. IF:8.500(Q1/2D).

01/07/2023 Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study

Marti-Aguado, D, Gougol, A, Gomez-Medina, C, Jamali, A, Abo-Zed, A, Morales-Arraez, D, Jimenez-Sosa, A, Burns, K, Bawa, A, Hernandez, A, Pujol, C, Alvarado-Tapias, E, Szafranska, J, Chiu, WK, Villagrasa, A, Ventura-Cots, M, Gandicheruvu, H, Lluch, P, Chen, HW, Rachakonda, V, Duarte-Rojo, A, Bataller, R. Prevalence and clinical impact of alcohol withdrawal syndrome in alcohol-associated hepatitis and the potential role of prophylaxis: a multinational, retrospective cohort study. Eclinicalmedicine. 2023; 61DOI:10.1016/j.eclinm.2023.102046. PMID:37415844. IF:9.600(Q1/1D).

28/06/2023 Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors

Barrabes-Torrella, C, Arandes-Marcocci, J, Armillas-Lliteras, L, Posada-Caez, RA, Koptseva, I, Fumagalli, C, Pinol-Ballus, D, Salleras-Redonnet, M. Sarcomatoid transformation of a basal cell carcinoma following treatment with hedgehog inhibitors. BRITISH JOURNAL OF DERMATOLOGY. 2023; 189(4)DOI:10.1093/bjd/ljad206. PMID:37378960. IF:11.000(Q1/1D).

01/06/2023 Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets

Barca, EG, Tomas-Roca, L, Esteve, A, Rodriguez, M, Gato, L, Alonso-Alonso, R, Garcia-Sancho, AM, Cordoba, R, Monter-Rovira, A, Bastos-Oreiro, M, Burgues, JMB, Sayas, MJ, Alegria, MCV, Sanchez-Blanco, JJ, Pellicer, MR, Henriquez, HDL, de Ona, R, Cabezudo, ME, Infante, MS, Hernandez, JAQ, Sanz-Pamplona, R, Blanco, O, Mozos, A, Climent, F, Piris, MA. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets. AMERICAN JOURNAL OF HEMATOLOGY. 2023; 98(6)DOI:10.1002/ajh.26904. PMID:36882876. IF:10.100(Q1/1D).

11/05/2023 The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel

Navarro-Perez, M, Estadella, I, Benavente-Garcia, A, Orellana-Fernandez, R, Petit, A, Ferreres, JC, Felipe, A. The Phosphorylation of Kv1.3: A Modulatory Mechanism for a Multifunctional Ion Channel. Cancers. 2023; 15(10)DOI:10.3390/cancers15102716. PMID:37345053. IF:4.500(Q1/3D).

01/05/2023 Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study

Espinosa, I, D'Angelo, E, De Brot, L, Prat, J. Malignant rhabdoid tumors of the vulva versus epithelioid sarcomas: a clinicopathologic, immunohistochemical, and molecular genetics study. HUMAN PATHOLOGY. 2023; 135DOI:10.1016/j.humpath.2023.02.006. PMID:36863690. IF:2.700(Q2/4D).

01/05/2023 Macrophage CD5L is a target for cancer immunotherapy

Sanchez-Moral, L, Paul, T, Martori, C, Font-Diaz, J, Sanjurjo, L, Aran, G, Tellez, E, Blanco, J, Carrillo, J, Ito, M, Tuttolomondo, M, Ditzel, HJ, Fumagalli, C, Tapia, G, Sidorova, J, Masnou, H, Fernandez-Sanmartin, MA, Lozano, JJ, Vilaplana, C, Rodriguez-Cortes, A, Armengol, C, Valledor, AF, Kremer, L, Sarriasa, MR. Macrophage CD5L is a target for cancer immunotherapy. EBioMedicine. 2023; 91DOI:10.1016/j.ebiom.2023.104555. PMID:37054630. IF:9.700(Q1/1D).

01/04/2023 Placental site trophoblastic tumor (PSTT): a case report and review of the literature

Zampacorta, C, Pasciuto, MP, Ferro, B, Lucidi, A, Maestro, AS, Espinosa, I, D'Angelo, E, Prat, J. Placental site trophoblastic tumor (PSTT): a case report and review of the literature. Pathologica. 2023; 115(2)DOI:10.32074/1591-951X-873. PMID:37114629. IF:(Q/D).

01/01/2023 CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study

Frezza A.M., Stacchiotti S., Chibon F., Coindre, JM, Italiano A., Romagnosa C., Bagué S., Dei Tos A.P., Braglia L., Palmerini E., Quagliuolo V., Broto J.M., Pousa, AL, Grignani G., Brunello A., Blay, JY, Beveridge R.D., Lugowska I., Lesluyes T., Maestro R., Merlo F.D., Casali P.G., Gronchi A.. CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study. Cancer Medicine. 2023; 12(2)DOI:10.1002/cam4.5015. PMID:35848358. IF:2.900(Q2/5D).

01/01/2023 Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models

Medina-Gutiérrez E., García-León A., Gallardo A., Álamo P., Alba-Castellón L., Unzueta U., Villaverde A., Vázquez E., Casanova I., Mangues R.. Potent Anticancer Activity of CXCR4-Targeted Nanostructured Toxins in Aggressive Endometrial Cancer Models. Cancers. 2023; 15(1)DOI:10.3390/cancers15010085. PMID:36612081. IF:4.500(Q1/3D).

01/01/2023 Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils

Cosio B.G., Shafiek H., Iglesias A., Mosteiro M., Gonzalez-Piñeiro A., Rodríguez M., García-Cosío M., Busto E., Martin J., Mejías L., Benito A., López Vilaro L., Gómez C.. Validation of a Pathological Score for the Assessment of Bronchial Biopsies in Severe Uncontrolled Asthma: Beyond Blood Eosinophils. ARCHIVOS DE BRONCONEUMOLOGIA. 2023; 59(8)DOI:10.1016/j.arbres.2023.05.014. PMID:37414638. IF:8.700(Q1/1D).

01/01/2023 Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease

Gené M., Cuatrecasas M., Amat I., Veiga J.A., Fernández Aceñero M.J., Fusté Chimisana V., Tarragona J., Jurado I., Fernández-Victoria R., Martínez Ciarpaglini C., Alenda González C., Zac C., Ortega de la Obra P., Fernández-Figueras M.T., Esteller M., Musulen E.. Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(10)DOI:10.3390/ijms24108655. PMID:37240002. IF:4.900(Q1/3D).